miR-200a Prevents Renal Fibrogenesis Through Repression of TGF-β2 Expression
Bo Wang(Diabetes Australia), Phillip Kantharidis(Diabetes Australia)
Cited by 355
Related Papers
Glucagon-like peptide-1 receptor signaling modifies the extent of diabetic kidney disease through dampening the receptor for advanced glycation end products–induced inflammation
|Kidney International|2023|121
Increased liver AGEs induce hepatic injury mediated through an OST48 pathway
|Scientific Reports|2017|33